CuroVax

Changzhou, China · Founded 2011 · Privately Held (backing)

Manufacturer of human vaccine products and immunization technologies aims to advance global public health through innovative vaccine development. CuroVax is based in Changzhou, China and was founded in 2011. Its last reported valuation was $405 million in Jan 2024. It has raised $74.2 million.

Last reported valuation

$405.0M

Oct 2026

Priced at

—

Total raised

$74.2M

Last round

—

How much has CuroVax raised?

$74.2Macross 0 recorded rounds

Free account

More of CuroVax with a free account

·The complete investor list: 18 names
·Watch CuroVax: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

CuroVax investors

18 investors are on record for CuroVax, including Qiming Venture Partners, Green Pine Capital Partners, Tailong VC and Hankang Capital.

For fundraisers

Raising for a company like CuroVax?

18 investors have backed CuroVax.

See all 18 investors →

Frequently asked about CuroVax

How much has CuroVax raised?: CuroVax has raised $74.2M in total across 0 recorded funding rounds.